Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis

Journal of Infectious Diseases

Volumn 190, Issue 11, 2004, Pages 1936-1940

  Harcourt, Jennifer L ^a   Karron, Ruth A ^c   Tripp, Ralph A ^a,b  

^a Division of Parasitic Diseases   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE CX3CR1; CHEMOKINE RECEPTOR; CX3C CHEMOKINE; FRACTALKINE; GUANINE NUCLEOTIDE BINDING PROTEIN ANTIBODY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS G PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; INFANT; LOWER RESPIRATORY TRACT INFECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; BINDING SITES, ANTIBODY; CHEMOKINES, CX3C; CHEMOTAXIS, LEUKOCYTE; CHILD, PRESCHOOL; HUMANS; INFANT; LEUKOCYTES; MEMBRANE PROTEINS; RECEPTORS, CHEMOKINE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VACCINATION; VACCINES, ATTENUATED; VIRAL PROTEINS;

EID: 9444263171     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425516     Document Type: Article

References (15)

1. Panitch HB. Bronchiolitis in infants. Curr Opin Pediatr 2001; 13: 256-60.
2. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440-6.
3. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163: 693-8.
4. Johnson PR Jr, Olmsted RA, Prince GA, et al. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol 1987;61:3163-6.
5. Varga SM, Braciale TJ. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology 2002; 295:203-7.
6. Tripp RA, Moore D, Jones L, Sullender W, Winter J, Anderson LJ. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 1999; 73:7099-107.
7. Tripp RA, Jones L, Anderson LJ. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol 2000; 74:6227-9.
8. Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J Virol 1998; 72:2871-80.
9. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2001; 2:732-8.
10. Wright PF, Gruber WC, Peters M, et al. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002; 185:1011-8.
11. Karron RA, Wright PF, Crowe JE Jr, et al. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis 1997; 176:1428-36.
12. Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM. Identification of CX3CR1: a chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 1998; 273:23799-804.
13. Wright PF, Karron RA, Belshe RB, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis 2000; 182:1331-42.
14. Haynes LM, Jones LP, Barskey A, Anderson LJ, Tripp RA. Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. J Virol 2003; 77:9831-44.
15. Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998; 188:1413-9.